While COVID-19 is predominantly a respiratory disease, growing evidence shows that patients with pre-existing cardiovascular disease (CVD) are at higher risk of developing more severe COVID-19, while post-COVID-19 infection, individuals may be prone to CVD 1,2,3
Reduction of Inflammation and Oxidative Stress : Research demonstrates that Glutathione reduces pro-inflammatory mediators such as TNF- and IL-6 while maintaining optimal nitric oxide levels
Haddad JJ: VX-745: Vertex Pharmaceuticals
Consequently, international buyers can coordinate compliant procurement for approved institutional, wholesale, or Named Patient Supply requirements
KPV provides the anti-inflammatory peptide in capsule and spray formats
Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis